Brain PET in Suspected Dementia: Patterns of Altered FDG Metabolism
The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Abstract
The diagnosis of dementia syndromes can be challenging for clinicians, particularly in the early stages of disease. Patients with higher education levels may experience a marked decline in cognitive function before their dementia is detectable with routine testing methods. In addition, comorbid conditions (eg, depression) and the use of certain medications can confound the clinical assessment. Clinicians require a high degree of certainty before making a diagnosis of Alzheimer disease or some other neurodegenerative disorder, since the impact on patients and their families can be devastating. Moreover, accurate diagnosis is important because emerging therapeutic regimens vary depending on the cause of the dementia. Clinically based testing is useful; however, the results usually do not enable the clinician to make a definitive diagnosis. For this reason, imaging biomarkers are playing an increasingly important role in the workup of patients with suspected dementia. Positron emission tomography with 2-[fluorine-18]fluoro-2-deoxy-D-glucose allows detection of neurodegenerative disorders earlier than is otherwise possible. Accurate interpretation of these studies requires recognition of typical metabolic patterns caused by dementias and of artifacts introduced by image processing. Although visual interpretation is a vital component of image analysis, computer-assisted diagnostic software has been shown to increase diagnostic accuracy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, sMRI and (18FDG)-PET indicate neurodegeneration or neuronal injury in the AT(N) framework with limitations in specifically diagnosing AD.”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [369]
In the citing paper
“They cannot accurately differentiate AD from other neurodegenerative diseases with similar pathologies, such as frontotemporal degeneration and TDP-43 proteinopathies with medial temporal lobe atrophy.”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [369]
Citations
Cites
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease
Minoshima, S., Giordani, B., Berent, S., Frey, K. A., Foster, N. L., & Kuhl, D. E. (1997) · Annals of Neurology · doi:10.1002/ana.410420114 · Cited by 1,802
Self-citationMosconi, L., Tsui, W. H., Herholz, K., Pupi, A., Drzezga, A., Lucignani, G., Reiman, E. M., Holthoff, V., Kalbe, E., Sorbi, S., et al. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.045385 · Cited by 726
Self-citationFDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease
Foster, N. L., Heidebrink, J. L., Clark, C. M., Jagust, W. J., Arnold, S. E., Barbas, N. R., DeCarli, C. S., Scott Turner, R., Koeppe, R. A., Higdon, R., et al. (2007) · Brain · doi:10.1093/brain/awm177 · Cited by 608
Self-citationFocal cortical presentations of Alzheimer's disease
Alladi, S., Xuereb, J., Bak, T., Nestor, P., Knibb, J., Patterson, K., & Hodges, J. R. (2007) · Brain · doi:10.1093/brain/awm213 · Cited by 581
White matter lesions impair frontal lobe function regardless of their location
Tullberg, M., Fletcher, E., DeCarli, C., Mungas, D., Reed, B. R., Harvey, D. J., Weiner, M. W., Chui, H. C., & Jagust, W. J. (2004) · Neurology · doi:10.1212/01.wnl.0000130530.55104.b5 · Cited by 530
Black, S., Gao, F., & Bilbao, J. (2009) · Stroke · doi:10.1161/strokeaha.108.537704 · Cited by 379
Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease
Chetelat, G., Desgranges, B., Landeau, B., Mezenge, F., Poline, J. B., de la Sayette, V., Viader, F., Eustache, F., & Baron, J.-C. (2007) · Brain · doi:10.1093/brain/awm288 · Cited by 339
What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia?
Jagust, W., Reed, B., Mungas, D., Ellis, W., & DeCarli, C. (2007) · Neurology · doi:10.1212/01.wnl.0000269790.05105.16 · Cited by 298
Positron emission tomography imaging in dementia
HERHOLZ, K., CARTER, S. F., & JONES, M. (2007) · The British Journal of Radiology · doi:10.1259/bjr/97295129 · Cited by 287
Research works printed but not linked: 3
- Jeong Y, 2005, J Nucl Med, 46, 233
- De Reuck J, 1997, Acta Neurol Belg, 97, 168
- Baron JC, 1982, J Nucl Med, 23, 391
Cited by
Items 101–200 of 259
Molecular Imaging of Dementia With Lewy Bodies
Cousins, O., Yousaf, T., Wilson, H., Pagano, G., & Politis, M. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.10.007 · Cited by 13
Magnetic resonance imaging in dementia
Rodríguez, L. R., Salazar, D. J. T., García, N. F., Hernández, L. P., & Guinea, Ó. F. (2018) · Radiología (English Edition) · doi:10.1016/j.rxeng.2018.07.004 · Cited by 16
Øen, S. K., Keil, T. M., Berntsen, E. M., Aanerud, J., Schwarzlmüller, T., Ladefoged, C. N., Karlberg, A. M., & Eikenes, L. (2019) · EJNMMI Research · doi:10.1186/s13550-019-0553-2 · Cited by 12
Z-score maps from low-dose 18F-FDG PET of the brain in neurodegenerative dementia.
Fällmar, D., Lilja, J., Danfors, T., Kilander, L., Iyer, V. V., Lubberink, M., Larsson, E., & Sørensen, J. (2018) · Europe PMC (PubMed Central) · Cited by 12
Planning in amnestic mild cognitive impairment: an fMRI study
Lejko, N., Tumati, S., Opmeer, E. M., Marsman, J.-B. C., Reesink, F. E., Deyn, P. P. D., Aleman, A., & Ćurĉić‐Blake, B. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111673 · Cited by 13
Lang, B., Kindy, M. S., Kozel, F. A., Schultz, S. K., & Taheri, S. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170733 · Cited by 12
Viglianti, B. L., Wale, D. J., Ma, T., Johnson, T. D., Bohnen, N. I., Wong, K. K., Ky, C., Frey, K. A., Townsend, D. M., Rubello, D., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108628 · Cited by 11
Self-citationShepherd, T. M., & Nayak, G. K. (2019) · Topics in Magnetic Resonance Imaging · doi:10.1097/rmr.0000000000000225 · Cited by 11
Patel, S., Porcari, P., Coffee, E., Kim, N., Berishaj, M., Peyear, T. A., Zhang, G., & Keshari, K. R. (2024) · Science Advances · doi:10.1126/sciadv.adr2058 · Cited by 10
Camedda, R., Bonomi, C. G., Donna, M. G. D., & Chiaravalloti, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24010751 · Cited by 10
An efficient method for detection of Alzheimer’s disease using high-dimensional PET scan images
Borji, A., Seifi, A., & Hejazi, T. (2023) · Intelligent Decision Technologies · doi:10.3233/idt-220315 · Cited by 15
Cistaro, A., Cassalia, L., Ferrara, C., Atzori, C., Vai, D., Quartuccio, N., Fania, P., Vaudano, G. P., & Imperiale, D. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8327-5 · Cited by 10
Ahmed, O., Franceschi, A., CLIFTON, M., Naser-Tavakolian, K., Cruciata, G., Bangiyev, L., Clouston, S., & Franceschi, D. (2020) · World Journal of Nuclear Medicine · doi:10.4103/wjnm.wjnm_62_20 · Cited by 13
Massa, F., Halbgebauer, S., Barba, L., Oeckl, P., José, N. G. D. S., Bauckneht, M., Lanfranchi, F., Vigo, T., Arnaldi, D., Pardini, M., et al. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.03.019 · Cited by 11
Mak, E., Przybelski, S. A., Wiste, H. J., Fought, A. J., Schwarz, C. G., Senjem, M. L., Jack, C. R., Lowe, V. J., Petersen, R. C., Boeve, B. F., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14571 · Cited by 13
Chetouani, A., Chawki, M. B., Hossu, G., Kearney‐Schwartz, A., Chauveau-Beuret, F., Bracard, S., Roch, V., Lebon, V., Marie, P., Bénétos, A., et al. (2017) · NeuroImage Clinical · doi:10.1016/j.nicl.2017.12.024 · Cited by 10
Xu, K., Niu, N., Li, X., Chen, Y., Wang, D., Zhang, J., Chen, Y., Li, H., Wei, D., Chen, K., et al. (2022) · Cerebral Cortex · doi:10.1093/cercor/bhac248 · Cited by 11
Wang, Y., Chen, S., Tian, X., Yuan, L., Han, D., Yao, P., Xu, H., Wang, Y., & Zhao, J. (2024) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2024.105551 · Cited by 9
Motara, H., Olusoga, T., Russell, G., Jamieson, S., Ahmed, S., Brindle, N., Pillai, A., Scarsbrook, A. F., Patel, C. N., & Chowdhury, F. U. (2016) · Clinical Radiology · doi:10.1016/j.crad.2016.08.003 · Cited by 10
Top-Down Systematic Approach to Interpretation of FDG-PET for Dementia
Sawyer, D. M., & Kuo, P. H. (2018) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000002115 · Cited by 9
Calabria, F. F., Leporace, M., Cimini, A., Ricci, M., Travascio, L., & Bagnato, A. (2023) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2206172 · Cited by 8
CD33 and SIGLECL1 Immunoglobulin Superfamily Involved in Dementia
Rendina, A., Drongitis, D., Donizetti, A., Fucci, L., Milan, G., Tripodi, F. S., Giustezza, F., Postiglione, A., Pappatà, S., Ferrari, R., et al. (2020) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaa055 · Cited by 10
Saka, E., Atay, L. Ö., Akdemir, Ü. Ö., Yetim, E., Balcı, E., Arsava, E. M., & Topçuoğlu, M. A. (2022) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x221124656 · Cited by 9
Iribarne, C., Renner, V., Pérez, C., & David Ladrón de Guevara, H. (2020) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2020.02.001 · Cited by 32
Hybrid PET/MRI with Flutemetamol and FDG in Alzheimer's Disease Clinical Continuum
Atay, L. Ö., Saka, E., Akdemir, Ü. Ö., Yetim, E., Balcı, E., Arsava, E. M., & Topçuoğlu, M. A. (2023) · Current Alzheimer Research · doi:10.2174/0115672050243131230925034334 · Cited by 8
Susceptibility weighted imaging in dementia with Lewy bodies: will it resolve the blind spot of MRI?
Haller, S., Fällmar, D., & Larsson, E. (2015) · Neuroradiology · doi:10.1007/s00234-015-1605-6 · Cited by 8
Hamed, M. A., Schraml, F. V., Wilson, J. R., Galvin, J. E., & Sabbagh, M. N. (2018) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000428 · Cited by 11
Franceschi, A. M., Naser-Tavakolian, K., Clifton, M. A., Ahmed, O. A., Stoffers, K., Bangiyev, L., Cruciata, G., Clouston, S., & Franceschi, D. (2020) · World Journal of Nuclear Medicine · doi:10.4103/wjnm.wjnm_27_20 · Cited by 8
Bøgh, N., Sørensen, C. B., Alstrup, A. K. O., Hansen, E. S. S., Andersen, O. M., & Laustsen, C. (2024) · Brain Communications · doi:10.1093/braincomms/fcae114 · Cited by 7
Thientunyakit, T., Muangpaisan, W., & Minoshima, S. (2025) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2025.04.007 · Cited by 8
Self-citationSun, Y., Bresell, A., Rantalainen, M., Höglund, K., Lebouvier, T., Salter, H., & Initiative, T. A. D. N. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142118 · Cited by 6
Bao, Y., Shea, Y. F., Chiu, P. K., Kwan, J. S. K., Chan, F. H.-W., & Mak, H. K. (2022) · Scientific Reports · doi:10.1038/s41598-022-14532-z · Cited by 7
Molecular Imaging with PET in the Assessment of Vascular Dementia and Cerebrovascular Disease
Patil, S., Patel, D., Kata, R., Teichner, E. M., Subtirelu, R. C., Ayubcha, C., Werner, T. J., & Alavi, A. A. (2024) · PET Clinics · doi:10.1016/j.cpet.2024.09.001 · Cited by 8
Hinge, C., Henriksen, O. M., Lindberg, U., Hasselbalch, S. G., Højgaard, L., Law, I. G., Andersen, F. L., & Ladefoged, C. N. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1053783 · Cited by 11
Effect of Obesity and Osteocalcin on Brain Glucose Metabolism in Healthy Participants
Shin, S., & Nam, H. (2023) · Brain Sciences · doi:10.3390/brainsci13060889 · Cited by 6
Chavan, R., Hyman, G., Qureshi, Z., Jayakumar, N., Terrell, W., Wardius, M., Berr, S. S., Schiff, D., Fountain, N. B., Muttikkal, T. J. E., et al. (2024) · Biomedical Physics & Engineering Express · doi:10.1088/2057-1976/ad6a64 · Cited by 7
From Matrices to Knowledge: Using Semantic Networks to Annotate the Connectome
Kopetzky, S. J., & Butz‐Ostendorf, M. (2018) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2018.00111 · Cited by 6
Utility of 18F FDG-PET in Parkinsonism in an African population
Amod, F., Bhigjee, A., & Nyakale, N. (2022) · eNeurologicalSci · doi:10.1016/j.ensci.2022.100399 · Cited by 6
Drake, D. F., Derado, G., Zhang, L., Bowman, F. D., & Initiative, A. D. N. (2023) · Wiley Interdisciplinary Reviews Computational Statistics · doi:10.1002/wics.1606 · Cited by 6
Shin, S., Seok, J. W., Kim, K., Kim, J. H., Nam, H., & Pak, K. (2024) · NeuroImage · doi:10.1016/j.neuroimage.2024.120814 · Cited by 6
Neuroimaging Biomarkers in Alzheimer’s Disease
Tripathi, S. M., Chutia, P., & Murray, A. D. (2025) · Journal of dementia and Alzheimer's disease · doi:10.3390/jdad2040037 · Cited by 8
Statistical Parametric Mapping in Amyloid Positron Emission Tomography
Smith, N. M., Ford, J. N., Haghdel, A., Glodzik, L., Li, Y., D’Angelo, D., RoyChoudhury, A., Wang, X., Blennow, K., de Leon, M. J., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.849932 · Cited by 5
Hedderich, D. M., Schmitz‐Koep, B., Schuberth, M., Schultz, V., Schlaeger, S., Schinz, D., Rubbert, C., Caspers, J., Zimmer, C., Grimmer, T., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.971863 · Cited by 7
Valencia-Cifuentes, V., Cañas, C. A., & Rivas, J. C. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1266419 · Cited by 5
Autoimmune Limbic Encephalitis Detected on FDG Brain Scan Performed for the Evaluation of Dementia
Thomas, A. C., Brown, R. K. J., Begum, R., Srinivasan, A., Bohnen, N. I., & Frey, K. A. (2015) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000000702 · Cited by 5
Self-citationResonancia magnética en las demencias
Rodríguez, L. R., Salazar, D. J. T., García, N. F., Hernández, L. P., & Guinea, Ó. F. (2018) · Radiología · doi:10.1016/j.rx.2018.04.003 · Cited by 11
Logopenic Variant Primary Progressive Aphasia
Roytman, M., & Chiang, G. C.-Y. (2021) · Springer eBooks · doi:10.1007/978-3-030-82367-2_27 · Cited by 5
Spano, M., Roytman, M., Aboian, M., Saboury, B., Franceschi, A. M., & Chiang, G. C.-Y. (2022) · PET Clinics · doi:10.1016/j.cpet.2022.09.006 · Cited by 8
Sarikaya, İ., Kamel, W. A., Ateyah, K., Essa, N., Altailji, S., & Sarıkaya, A. (2021) · World Journal of Nuclear Medicine · doi:10.4103/wjnm.wjnm_53_18 · Cited by 6
Loewenstein, D. S. L., van Grinsven, M., de Pont, C., DAUTZENBERG, P. L. J., van Strien, A. M., & Henssen, D. J. H. A. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01604-7 · Cited by 4
Metabolic brain networks in dementia with Lewy bodies: from prodromal to manifest disease stages
Perovnik, M., Simončič, U., Jamšek, J., Kramberger, M. G., Brumberg, J., Meyer, P. T., Perani, D., Caminiti, S. P., Brendel, M., Stockbauer, A., et al. (2025) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2025-336935 · Cited by 7
Mitigation of CXCL10 secretion by metabolic disorder drugs in microglial-mediated neuroinflammation
Oliai, S. F., Shippy, D. C., & Ulland, T. K. (2024) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2024.578364 · Cited by 5
Atypical presentation of progressive young onset dementia
Elhusein, B., Radwan, A., Khairi, A. A. B., & Ahmed, M. E. (2018) · BMJ Case Reports · doi:10.1136/bcr-2018-225754 · Cited by 5
Herscovitch, P. (2020) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.252510 · Cited by 5
Effect of Alzheimer’s Disease and Lewy Body Disease on Metabolic Changes
Lee, Y. H., Jeon, S., Yoo, H. S., Chung, S. J., Jung, J. H., Baik, K., Sohn, Y. H., Lee, P. H., Yun, M., Evans, A. C., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201094 · Cited by 6
Franceschi, A. M., Naser-Tavakolian, K., Clifton, M. A., Bangiyev, L., Cruciata, G., Clouston, S., & Franceschi, D. (2021) · World Journal of Nuclear Medicine · doi:10.4103/wjnm.wjnm_137_20 · Cited by 4
Biomarkers of Alzheimer’s Disease
Saeed, U., Swardfager, W., Black, S. E., & Masellis, M. (2017) · Mental health and illness worldwide · doi:10.1007/978-981-10-2414-6_8 · Cited by 4
Mettler, F. A., & Guiberteau, M. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-48319-3.00003-1 · Cited by 4
Sohn, B., Chung, S. J., Lee, J. R., Hwang, D., Xie, W., Chan, L. L., Choi, Y. S., Study, H. B. I., Initiative, J. A. D. N., & Initiative, A. D. N. (2024) · Radiology Advances · doi:10.1093/radadv/umae021 · Cited by 3
ACR–ACNM–ASNR–SNMMI Practice Parameter for the Performance of Brain PET/CT Imaging in Dementia
Tu, R. K., Esposito, G., Agarwal, A., Akin, E. A., Catana, C., Chiang, G. C.-Y., Colletti, P. M., Dhingra, J., Kuo, P. H., Franceschi, A. M., et al. (2026) · American Journal of Neuroradiology · doi:10.3174/ajnr.a9105 · Cited by 3
Gallet, Q., Bouteloup, V., Locatelli, M., Habert, M., Marie Chupin, A., Campion, J., Michels, P.-E., Delrieu, J., Lebouvier, T., Balageas, A., et al. (2023) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2023.10.002 · Cited by 3
Rullmann, M., Henssen, D. J. H. A., Melasch, J., Scherlach, C., Saur, D., Schroeter, M. L., Tiepolt, S., Koglin, N., Stephens, A. W., Hesse, S., et al. (2025) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-025-07135-z · Cited by 4
Changing landscapes in the neuroimaging of dementia
Ranganathan, L. N., Guhan, R., Shivaraman, M. A., LeninSankar, P., Srinivasan, A. V., Suriyakumar, G., & Periakaruppan, A. L. (2018) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_48_18 · Cited by 4
Morgan, R., Prosapio, J., Kara, S., Sonty, S., Youssef, P., & Nedd, K. (2021) · Interdisciplinary Neurosurgery · doi:10.1016/j.inat.2021.101290 · Cited by 3
Pasini, E., Genovesi, D., Rossi, C. A., Santi, L. A. D., Positano, V., Giorgetti, A., & Santarelli, M. F. (2022) · Electronics · doi:10.3390/electronics11142260 · Cited by 3
de Oliveira, C. E. G., de Araújo, W. M., Teixeira, A. B. M. D. J., GONÇALVES, G. B., Itikawa, E. N., & Initiative, A. D. N. (2023) · Physics in Medicine and Biology · doi:10.1088/1361-6560/ad0ddd · Cited by 4
BESTETTI, A., Calabrese, L., Parini, V., & Fornara, C. (2024) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000001810 · Cited by 3
Cognitive Impairment in the Primary Care Clinic
Womack, C. L., Perkins, A., & Arnold, J. M. (2024) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2024.02.010 · Cited by 4
BESTETTI, A., Zangheri, B., Gabanelli, S. V., Parini, V., & Fornara, C. (2024) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000001853 · Cited by 3
Structural and Functional Imaging
Aga, V. M. (2018) · Springer eBooks · doi:10.1007/978-3-319-73078-3_15 · Cited by 3
Vadalà, M., Cistaro, A., Quartuccio, N., Calcagni, M. L., Fania, P., Margotti, S., Schiera, I. G., Laurino, C., & Palmieri, B. (2020) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000001280 · Cited by 4
Mathies, F. L., Lange, C., Maeurer, A., Apostolova, I. I., Klutmann, S., & Buchert, R. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200530 · Cited by 4
Park, K., Jung, J., Choi, Y., Leem, H., & Kim, Y. (2021) · Sensors · doi:10.3390/s21165566 · Cited by 3
Patterns of neurodegeneration in dementia reflect a global functional state spacePreprint
Jones, D. T., Lowe, V. J., Graff-Radford, J., Botha, H., Wiepert, D. A., Murphy, M. C., Murray, M. E., Senjem, M. L., Gunter, J. L., Wiste, H. J., et al. (2020) · medRxiv · doi:10.1101/2020.11.09.20228676 · Cited by 3
Cerina, V., Crivellaro, C., Morzenti, S., Pozzi, F. E., Bigiogera, V., Jonghi-Lavarini, L., Moresco, R. M., Basso, G., & Bernardi, E. D. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e23340 · Cited by 2
Sink-index: a network-based EEG marker for frontotemporal dementia and Alzheimer’s disease
Sanchez, L. A., Pandiaraju, S., Williams, A. O., Daraie, A. H., Onyike, C. U., & Sarma, S. V. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf259 · Cited by 2
Diagnostic Impact of Cerebrospinal Fluid Biomarkers in Atypical Dementias in Canada
van den Brink, S. E. M., Amrani, L. E., Therriault, J., Gauthier, S. G., Rosa‐Neto, P., & Vitali, P. (2020) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2020.196 · Cited by 2
Sawyer, D. M., Sawyer, T. W., Eshghi, N., Hsu, C. C.-C., Hamilton, R. J., Garland, L. L., & Kuo, P. H. (2020) · Journal of Nuclear Medicine Technology · doi:10.2967/jnmt.120.248393 · Cited by 2
Neurology Evaluation in Dementia and Neurodegenerative Disease
Giliberto, L. (2021) · Springer eBooks · doi:10.1007/978-3-030-82367-2_20 · Cited by 3
Statistical Inference for Mean Functions of Complex 3D Objects
Wang, Y., Wang, G., Klinedinst, B. S., Willette, A. A., & Wang, L. (2023) · Statistica Sinica · doi:10.5705/ss.202023.0071 · Cited by 2
Ricaurte‐Fajardo, A., Franceschi, A. M., Angelo, D., McCalla, A., Salgado, M. W., Hamed, M. A., Intorcia, B., Wisherop, C., Keil, S. A., Nordvig, A. S., et al. (2025) · American Journal of Neuroradiology · doi:10.3174/ajnr.a8698 · Cited by 2
Bohnen, N. I., Haugen, J., Kluin, K. J., & Kotagal, V. (2016) · Case Reports in Neurological Medicine · doi:10.1155/2016/8941035 · Cited by 2
Self-citationBrain Imaging Techniques: Improving the Quality
Noble, R. M. (2021) · Journal of Nuclear Medicine Technology · doi:10.2967/jnmt.120.257592 · Cited by 2
Clifton, M. A., Naser-Tavakolian, K., & Franceschi, A. M. (2021) · Springer eBooks · doi:10.1007/978-3-030-82367-2_39 · Cited by 2
Neurodegenerative Disorders: Classification and Imaging Strategy
Haller, S., Garibotto, V., & Barkhof, F. (2019) · Springer eBooks · doi:10.1007/978-3-319-68536-6_78 · Cited by 2
Chotipanich, C., Hirata, N., Jantarato, A., Kiatkittikul, P., Siripongsatian, D., Kunawudhi, A., Promteangtrong, C., Tieojaroenkit, N., Vanprom, S., & Mahanonda, N. (2022) · Journal of medical imaging · doi:10.1117/1.jmi.9.6.064501 · Cited by 2
The role of nuclear medicine in central nervous system evaluation
Shadmani, G., Swingle, C. A., & Coffman, C. H. (2025) · The Neuroradiology Journal · doi:10.1177/19714009251345100 · Cited by 1
Katiyar, D., & Manish, M. (2025) · Letters in Drug Design & Discovery · doi:10.1016/j.lddd.2025.100126 · Cited by 2
Gad, M. M., Deng, F., Prasuhn, J., & Luna, L. (2026) · The Neuroradiology Journal · doi:10.1177/19714009261423704 · Cited by 2
Loewenstein, D., van Grinsven, M., de Pont, C., Arens, A. I. J., DAUTZENBERG, P. L. J., van Strien, A. M., Sabri, O., Hesse, S., Rullmann, M., Henssen, D. J. H. A., et al. (2026) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-026-07925-z · Cited by 1
Molecular Imaging and Precision Medicine in Dementia and Movement Disorders
Mallik, A. K., Drzezga, A. E., & Minoshima, S. (2016) · PET Clinics · doi:10.1016/j.cpet.2016.08.003 · Cited by 1
Self-citation123I-FP-CIT and 99mTc-HMPAO in Pathologically Confirmed Progressive Supranuclear Palsy
Matesan, M. C., Elojeimy, S. N., & Minoshima, S. (2016) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001400 · Cited by 1
Self-citationNeurodegenerative Disorders: Classification and Imaging Strategy
Haller, S., Garibotto, V., & Barkhof, F. (2018) · Springer eBooks · doi:10.1007/978-3-319-61423-6_78-1 · Cited by 1
Aziz, S. A. A., Ling, L. J., Saad, F. F. A., Nordin, A. J., Ibrahim, N., Nuruddin, A., Tunan, E., Rosalina, Saripan, M. I., & Suppiah, S. (2019) · Medical Journal of Indonesia · doi:10.13181/mji.v28i3.2770 · Cited by 1
Behavioral Variant Frontotemporal Dementia
Ford, J. N., & Chiang, G. C.-Y. (2021) · Springer eBooks · doi:10.1007/978-3-030-82367-2_26 · Cited by 2
Monotonic Gaussian Process for spatio-temporal disease progression modeling in brain imaging data
Nader, C. A., Ayache, N., Robert, P. H., & Lorenzi, M. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.116266 · Cited by 31
Recognizing common PET patterns in neurodegenerative dementia
Chen, Y. J., Dubroff, J. G., & Nasrallah, I. M. (2017) · Applied Radiology · doi:10.37549/ar2385 · Cited by 2
The Utility of Molecular Imaging for Investigating Patients with Visual Hallucinations
Clifford, S. M., Purcell, Y., & Killeen, R. P. (2016) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4937
Nuclear Medicine Methods in Dementia
Budak, E. S., & Aydın, F. (2016) · Nuclear Medicine Seminars · doi:10.4274/nts.2016.020 · Cited by 2
Biomarkers of Alzheimer’s Disease
Saeed, U., Swardfager, W., Black, S. E., & Masellis, M. (2017) · Mental health and illness worldwide · doi:10.1007/978-981-10-0370-7_8-1 · Cited by 1
Metadata
- Authors
- Brown, R. K. J., Bohnen, N. I., Wong, K. K., Minoshima, S., & Frey, K. A.
- Affiliations
- University of Washington (US)
- University of Michigan (US)
- Venue
- RadioGraphics
- Published
- 2014-05
- Volume
- 34
- Issue
- 3
- Pages
- 684-701
- ISSN
- 0271-5333 (ISSN-L)
- 1527-1323
- OpenAlex
- W2141562510
- Cited by
- 256
- References
- 76
- Citations by year
- 2026: 13 · 2025: 19 · 2024: 24 · 2023: 22 · 2022: 30 · 2021: 27 · 2020: 28 · 2019: 22 · 2018: 24 · 2017: 20 · 2016: 18 · 2015: 7 · 2014: 1
- FWCI
- 11.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Radiographics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- dementia, FDG-PET, FDG metabolism, Alzheimer's disease, neurodegenerative diseases, imaging biomarkers, early diagnosis, image artifacts, computer-aided diagnosis, visual interpretation, comorbid depression
- MeSH terms
- Brain, Dementia, Diagnosis, Differential, Humans, Image Processing, Computer-Assisted, Tissue Distribution, Artifacts, Radiopharmaceuticals, Neurodegenerative Diseases, Fluorodeoxyglucose F18, Early Diagnosis, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.